Specifically, IRAK3 has been shown to substantially suppress neuroinflammation in mice with autoimmune encephalomyelitis, middle cerebral artery occlusion, or sub-acute Parkinson's disease, thereby reducing brain edema, improving the blood–brain barrier, decreasing neuronal death, and finally recovering neurological function (11–13). The gene discussed is IRAK3; the disease is Parkinson disease.